¡°	crystallize ranitidine	13.227952979750896
¡°	Interchem ranitidine	10.259432476920741
¡°	drug ranitidine	8.600711762763899
¡°	form ranitidine hydrochloride	6.466214963422426
¡°	improved form ranitidine	6.4519930889205135
	Tor Pharm Inc.	5.104286409188554
¡°	improve form ranitidine novelty	4.340939657437194
¡°	improve form ranitidine lack	4.304959106473147
	Tor Pharm assertion	3.828416349441219
	Tor Pharm response	3.828268038696354
	Tor Pharm appeal	3.8282148068914155
¡°	improve form ranitidine product	3.2286951991516197
	ml tap density	2.951106528348715
	argument	2.57974116378872
	Ochiai	2.500146489066009
	Interchem Corporation	2.4974010120743086
	neither Interchem	2.4964979418410786
	ii tap density	2.3624793695476733
	specified bulk tap density limitation	2.199263141067112
	obviousness challenge	1.9349398128991213
	Tor Pharm. Quality test	1.8686885136111435
	form Ranitidine Hydrochloride	1.7728172365758492
	bulk density	1.4483375415881934
	Genpharm	0.9619069568574686
	Welch	0.8342030947021544
	least one alkanol	0.8330008602340695
	isopropyl alcohol	0.7964804450150118
	acceptable filtration	0.7250018616011283
	substantially anhydrous hydroxylic solvent	0.5841102116044862
	specify density	0.5787105984090626
	subsequent negation	0.48352317463284006
	collateral estoppel	0.43293689659912693
	three- four carbon alcohol solvent	0.4182347563481795
	ml.1 Idaho	0.4171025584406385
	North Carolina litigation	0.4068695908027481
	North Carolina decision	0.4057781501110691
	North Carolina district court	0.32461682368970984
	undesirable drying filtration characteristic	0.29134828811148955
	E.D.N.C. March	0.27835004996017326
	ulcer drug	0.21041787114769062
¡°	different crystalline form	0.18546526679642514
	large sized crystal	0.1395572416337456
	three lot	0.13924819919445416
¡°	original crystalline form	0.13924379365157824
	Roebuck	0.11892016411253753
	acid secretion	0.10604487624838953
	Sears	0.10289495590033437
	antihistamine drug	0.09032108571375737
	alleged novelty	0.07265701986646735
	Geneva Pharmaceuticals Inc. Idaho	0.06842373333578393
	novel nonobvious product	0.059426861036997826
	Ben Venue Labs. Inc.	0.051800360376873134
	New Jersey	0.04564451567435422
	conversely process	0.04178071959369795
	plenary review	0.03969448457556287
	stipulation	0.032588834587110434
	reconsideration	0.032588834587110434
	conflicting decision	0.03156808375684411
	divisional	0.021181606620131747
	court specialized jurisdiction	0.020592562683996913
	subsequent invalidation	0.017881648955595
	nonobviousness	0.01622602863875275
	unrelated litigation	0.013221574430544076
	prosecution history estoppel	0.012179810088375398
	false distinction	0.007651737151193013
	per se rule	0.007336833408388376
	LLC	0.004580073454401808
	patentability	0.004548246658793463
	Third Circuit	0.004538972034318024
	two property	0.004350095367955996
	chemical	0.004266496181290915
	extensive litigation	0.004219903377247151
	two principal requirement	0.004161145212730028
	anything	0.004140290386606144
	legal consequence	0.0040690496077337625
	amendment	0.003415234292472279
	deference	0.0032235479419068453
	several pharmaceutical manufacturer	0.003021589233970615
	initial ruling	0.002979954156022331
	initial decision	0.0029095309491299717
	regional circuit law	0.0026779841696900667
	comparison	0.002410309395220279
	distinct question	0.00240797418778683
	either direction	0.0019202355230719982
	priority application	0.0018661538965074372
	prior sale	0.0016189455903179836
	section	0.0014049151899583419
	anticipation	0.0012580796645265458
	prevail party	0.0010932196822074282
	filing	0.000979863314989132
	obviousness rejection	0.000904690024085555
	abuse	0.0008899934062374124
	owner	0.0008861815916291187
	one hand	0.000767133711608504
	representative	0.0007671330447728402
	discretion	0.000569499165884154
	summary judgment	0.00027152528813522906
	invalidity	0.0002535400962386492
	underlie factual finding	0.0001354485797789275
	legal determination	7.676952141593991e-05
	well know product	4.3466440047575236e-05
	suit	1.715069480939499e-05
	dispute material fact	1.6227194855611812e-05
	reason	1.2447197927452212e-05
	error	1.1836698601325983e-05
	specification	5.71689826979833e-06
	district court decision	5.702319706197005e-06
	order	4.40782078169259e-06
	relevant prior art	1.4269492946817607e-06
	district court application	8.193383822533596e-07
	trial court	6.617460675875033e-07
	evidence	5.521550742271439e-08
	invention	3.5761848378449257e-09
	issue	1.0997306392830683e-09
	Co.	5.576044460508493e-10
	District	0.0
	Court	0.0
	Appeals	0.0
	Fed	0.0
